Skip to main content
. 2020 Dec 7;11:518837. doi: 10.3389/fpsyt.2020.518837

Table 1.

Comparison of the demographic, clinical, and treatment characteristics between healthy controls and patients with MDD.

Variables Healthy control MDD Comparisons
t/χ2a p
Cases [n] 30 57 - -
Age (years) [mean (SD)] 58.1 (15.1) 57.0 (10.6) 0.383 0.671
Age range (years) 29–82 29–77 - -
Female [n (%)] 16 (53.3) 46 (80.7) χ2 = 7.189 0.007
Education (years) [mean (SD)] 7.3 (3.4) 7.7 (3.0) t = 0.521 0.604
Marriage_Single [n (%)] 1 (3.3) 6 (10.5) χ2 = 1.998 0.573
Marriage_Married [n (%)] 25 (83.3) 42 (73.7)
Marriage_Divorce [n (%)] 3 (10.0) 5 (8.8)
Marriage_Widowed [n (%)] 1 (3.3) 4 (7.0)
Family History [n (%)] 0 (0) 6 (10.5) χ2 = 1.951 0.163
Age of MDD onset (years) [mean (SD)] - 48.4 (14.2) - -
No. of MDD episode [mean (SD)] - 2.6 (1.8) - -
No. of hospitalization [mean (SD)] - 1.8 (1.5) - -
Course (months) [mean (SD)] - 8.5 (8.6) - -
Baseline HAM-D [mean (SD)]
HAM-D total score [n (%)] - 30.8 (4.8) - -
HAM-D factor-1: anxiety/somatization - 8.5 (3.0) - -
HAM-D factor-2: weight - 1.1 (0.9) - -
HAM-D factor-3: cognitive disturbance - 3.6 (2.4) - -
HAM-D factor-4: retardation - 2.1 (0.9) - -
HAM-D factor-5: diurnal variation - 6.4 (1.6) - -
HAM-D factor-6: sleep disorder - 4.9 (1.5) - -
HAM-D factor-7: desperation - 4.2 (1.9) - -
Antidepressants (mg per day) [mean (SD)]
Duloxetine - 5 (8.8) - -
Escitalopram - 26 (45.6) - -
Paroxetine - 14 (24.6) - -
Venlafaxine - 12 (21.1) - -
Fluoxetine-equivalent dose - 75.8 (94.7) - -
Week 2 - -
HAM-D total score [mean (SD)] - 15.8 (3.2) - -
Δ1 HAM-D [mean (SD)]b - 15.0 (3.1) - -
Δ1 HAM-D improvement rate (%) [mean (SD)]c - 48.8 (6.5) - -
Week 12 - -
HAM-D total score [mean (SD)] - 7.5 (2.0) - -
Δ2 HAM-D [mean (SD)]d - 23.3 (4.8) - -
Δ2 HAM-D improvement rate (%) [mean (SD)]e - 75.2 (6.7) - -
a

t/χ2: t for t test, χ2 for kappa test.

b

Δ1. HAM-D: baseline HAM-D—week 2 HAM-D.

c

Δ1 HAM-D improvement rate (%): (baseline HAM-D—week 2 HAM-D)/baseline HAM-D.

d

Δ2. HAM-D: baseline HAM-D—week 12 HAM-D.

e

Δ2 HAM-D improvement rate (%): (baseline HAM-D—week 12 HAM-D)/baseline HAM-D.

Significant P values are bolded.